ESC Congress 2021

Join our scientific sessions and learning activities to see how our life-changing cardiovascular technologies help people live better lives.

Scientific sessionsAdd events to your calendar

  • VASCULAR SAT 28 AUGUST 2021 | 09:00 -09:30 CEST

    ESC Symposium: Why we should not settle for 'ongoing angina' - Channel 2

    Chairpersons  F. Crea (Roma, IT) - T. Ford (Clovelly, AU)

    09:00   Introduction & relevance of INOCA. T. Ford (Clovelly, AU)

    09:06   The importance of a complete invasive diagnosis of the INOCA patient. T. Engstrom (Copenhagen, DK)

    09:13   Live Questions & Answers. T. Engstrom (Copenhagen, DK) 

    09:17   The optimal patient pathway - how it looks like in our hospital.  F. Crea (Roma, IT)

    09:24   Live Questions & Answers.  F. Crea (Roma, IT)

    09:29  Take home messages.  F. Crea (Roma, IT)

    Learning Objectives:

    1. Understand the burden of recurrent and persistent angina in patients with INOCA
    2. Learn how a complete diagnosis is important for initiating adequate treatment and ending a vicious circle of diagnostic uncertainty.
    3. Learn how a practical set up of an INOCA clinic can address both patient and HCP needs

     

    REGISTER    LEARN MORE

  • DIABETES MON 30 AUGUST 2021 | 09:00 -09:30 CEST

    ESC SYMPOSIUM: Modern Glycaemic Management to reduce CV risk in Diabetes - CHANNEL 1

    Chairpersons  N. Marx (Aachen, DE)

    09:00   Introduction N. Marx (Aachen, DE)

    09:03   Adverse glycaemic measures in cardiac patients: HbA1c fails to provide the full picture. R. Ajjan (Leeds, GB) 

    09:13   Is continuous glucose monitoring the solution?  GA Lanza (Rome, IT)

    09:23   Live Questions & Answers.  N. Marx (Aachen, DE)

    Learning Objectives:

    Session participants will learn the importance of modern glycaemic management for the cardiovascular outcome of their patients.

     

    REGISTER    LEARN MORE

  • HEART FAILURE MANAGEMENT MON 30 AUGUST 2021 | 13:00 -13:45 CEST

    ESC SYMPOSIUM: The Global problem of Heart failure: what options when drug therapy is not enough? - CHANNEL 5

    Chairpersons  J. Bax (Leiden, NL) - M. Metra (Brescia, IT) 

    13:00   Introduction. M. Metra (Brescia, IT) 

    13:02   Heart Failure - A complex treatment for a complex condition. W. Mullens (Genk, BE) 

    13:09   Optimizing patient outcome by using advanced medical device therapies. F. Schoenrath (Berlin, DE) 

    13:16   Optimizing our approach of Valvular heart diseases. R. Von Bardeleben (Mainz, DE)

    13:23   Your access to powerfully connected patients. M. Taborsky (Olomouc, CZ) 

    13:30   Discussion - All

    13:42   Take-home messages. J. Bax (Leiden, NL)

     

    Learning Objectives:

    Better understand the value of device therapies in optimizing heart failure management at every stage; from diagnosis to follow-up. 
    Understand why it is important to treat valvular diseases in heart failure and the recent guidelienes and evidences published.

     

    REGISTER    LEARN MORE

  • DIAGNOSTICS MON 30 AUGUST 2021 | 13:00 -13:45 CEST

    ESC SYMPOSIUM: Cardiovascular risk assessment and prevention: Where do we stand now? - CHANNEL 4

    Chairpersons  CS Lam (Singapore, SG) 

    13:00   Welcome & Introduction. CS Lam (Singapore, SG) 

    13:05   The role of troponins in primary prevention of CV events: Case report. N. Sattar (Glasgow, GB) 

    13:15   Practical recommendations for the management of patients with CV disease by using hsTnI. T. Omland (Oslo, NO)

    13:25   The confirmed role of LDL-cholesterol for the prevention and management of cardiovascular disease in patients with diabetes.  G. Rudofsky (Olten, CH) 

    13:35   Live Questions & Answers.  CS Lam (Singapore, SG), N Sattar (Glasgow, GB), T Omland (Oslo, NO), G Rudofsky (Olten, CH) 

    Learning Objectives:

    Cardiac biomarkers and lipids might play a major role in the prevention of cardiovascular diseases. Join this session to learn from experts in cardiovascular disease prevention about the recent evidence on risk stratification, to get insights from their daily clinical practice and to learn how to use cardiac biomarkers and lipid profile in a more efficient way.

     

    REGISTER    LEARN MORE

Tutorials

Limited attendance allowed- please register (First come, first served) via ESC platform from August 26th.

  • Transcatheter Mitral Valve repair therapy SAT 28 & MON 30 AUGUST 2021

    From Diagnosis to Follow-up

    Sessions | 08:00 - 09:10 Session Mitral A | 09:20 - 10:30 Session Mitral B
    Disease, diagnosis
    J. Bax (Leiden, NL)

    Screening
    A. Coisne (Lille, FR)

    Deep-dive into the established transcatheter mitral valve edge to edge repair therapy
    C. Wolf, EMEA Education & Training Department, Abbott Structural Heart (Diegem, BE)

    Follow-up
    L. Badano (Padova, IT)
     

    Tips & Tricks Hands-On
    10:30 - 11:30 | Mitral valve: How to maximize the Echomodalities.
    K. Benekos (GE Training manager)
    Register now


    Happy Hour
    18:00 - 18:30 | Questions & Answers 
    J. Bax, A. Coisne, C. Wolf, L. Badano, K. Benekos

  • Transcatheter Tricuspid valve repair SAT 28 & MON 30 AUGUST 2021

    From Diagnosis to Follow-up

    Sessions | 14:00 - 15:10 Session Tricuspid A | 15:20 - 16:30 Session Tricuspid B
    Disease, diagnosis
    J. Bax (Leiden, NL)

    Screening
    E. Donal (Rennes, FR)

    Deep-dive into the transcatheter tricuspid valve edge to edge repair therapy
    M. Santopaolo, EMEA Education & Training Department, Abbott Structural Heart (Pavia, IT)

    Follow-up
    M. Sitges (Barcelona, ES)
     

    Tips & Tricks Hands-On
    16:30 - 17:30 | Mitral valve: How to maximize the Echomodalities.
    K. Benekos (GE Training manager)
    Register now


    Happy Hour
    18:00 - 18:30 | Questions & Answers 
    J. Bax,E. Donal, M. Santopaolo, M. Sitges, K. Benekos

  • LAAO - Stroke prevention with device therapy SUN 29 AUGUST 2021

    From Diagnosis to Follow-up

    Sessions | 15:00 - 16:00 Session LAAO A | 16:00 - 17:00 Session LAAO B
    Disease & Screening echo (AF triggered stroke)
    L. Sanchis Ruiz (Barcelona, ES)

    Deep-dive into the LAA Occlusion
    A. Aminian (Waterloo, BE)

    Follow-up
    L. Sanchis Ruiz (Barcelona, ES)
     

    Tips & Tricks Hands-On
    17:00 - 18:00 | LAAO: How to maximize the Echomodalities (TEE & TTE).
    K. Benekos (GE Training manager)
    Register now


    Happy Hour
    18:30 - 19:00 | Questions & Answers - Special LAA Occlusion
    L. Sanchis Ruiz, A. Aminian, K. Benekos

  • PFO closure - Stroke prevention with device therapy SUN 29 AUGUST 2021

    From Diagnosis to Follow-up

    Sessions | 08:00 - 9:00 SESSION PFO A | 09:00 - 10:00 SESSION PFO B
    Disease & Screening
    J.D. Kasprzak (Lodz, PL)

    Deep-dive into the PFO Closure
    A. Aminian (Waterloo, BE)

    Follow-up
    J.D. Kasprzak (Lodz, PL)
     

    Tips & Tricks Hands-On
    10:30 - 11:00 | PFO Closure: How to maximize the Echomodalities (TEE & TTE).
    K. Benekos (GE Training manager)
    Register now


    Happy Hour
    18:00 - 18:30 | Questions & Answers - Special PFO Closure
    J.D. Kasprzak, A. Aminian, K. Benekos

Information

Vascular

Assessing the microcirculation with PressureWire™ X Guidewire: CFR/IMR

Heart Failure management

Cardiac Resynchronization Therapy

Transcatheter Mitral Valve repair therapy

Transcatheter Mitral Valve Replacement Therapy

Transcatheter Tricuspid Valve Repair

Pulmonary artery pressure monitoring

Left Ventricule Assist Device Therapy

Sign Up

Register to stay updated on latest news about Mitral Regurgitation, Aortic Stenosis, Heart Failure management and Stroke Prevention.

Register now

Unless otherwise specified, all product and service names appearing herein are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name or trade dress may be made without their prior written authorization of Abbott. Products intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use provided inside the product carton (when available) or at eifu.abbottvascular.com or at medical.abbott/manuals for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events. All drawings are artist's representations only and should not be considered as engineering drawings or photographs. Photo(s) on file at Abbott. Information contained herein is for distribution for Europe, Middle East and Africa ONLY. Please check the regulatory status of the device before distribution in areas where CE marking is not the regulation in force.

Abbott International BVBA, Park Lane, Culliganlaan 2b, 1831 Diegem, Belgium, tel: +32 2 714 14 11
© 2021 Abbott. All rights reserved. 9-EH-5-12450-01 07-2021.

You are about to leave AdvancedHeartTherapies.com

You are now leaving AdvancedHeartTherapies.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.